Tian Ming, Qing Chun, Cao Xiao-Zan, Niu Yi-Wen, Lu Shu-Liang
Shanghai Institute of Burns, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zhonghua Shao Shang Za Zhi. 2011 Feb;27(1):21-5.
To investigate the effects of aminoguanidine cream on the proliferation of keratinocytes (KC), content of advanced glycosylation end products (AGE) and oxidative stress in skin tissue of rats with diabetes.
Stearic acid, liquid paraffin, vaseline, lanolin, isopropyl myristate fat, glycerol, 50 g/L alcohol paraben, aminoguanidine hydrochloride etc. were mixed in certain proportion to make aminoguanidine cream, and cream without aminoguanidine was used as matrix. The dorsal skin of normal rats were harvested and treated by aminoguanidine cream with dose of 5, 10 g/L, or 5 g/L together with 10 g/L azone. The transdermal effect was respectively measured at post treatment hour 2, 4, 7, 10, 12, 24. Thirty SD rats were divided into normal control (NC, n = 6), diabetes (D, n = 8), aminoguanidine cream-interfered (AI, n = 8), matrix cream-interfered groups (MI, n = 8) according to the random number table. Diabetes was reproduced by intraperitoneal injection of STZ (65 mg/kg) in rats of D, AI, and MI groups, and rats in NC group were injected with 0.05 mmol/L citrate buffer as control. One week later, dorsal skin of rats in AI and MI groups were respectively treated with 10 g/L aminoguanidine cream and matrix cream by external use for 4 weeks. AGE content was determined with fluorescence detection from skin collagen extract. KC cell cycle was detected by flow cytometry. Skin tissue specimens were obtained for determination of levels of superoxide dismutase (SOD), malondialdehyde (MDA), myeloperoxidase (MPO), and total antioxidant capacity. Data were processed with t test.
Transdermal effect of aminoguanidine cream with dose of 10 g/L was better than that with 5 g/L or 5 g/L + 10 g/L azone cream. One rat was not induced successfully in MI group. Four weeks after model reproduction, 4 rats died in D group and 1 rat died in AI group. The AGE content in D group was obviously higher than that in NC group [(36.8 +/- 2.6), (24.6 +/- 2.7) U per milligram hydroxyproline, respectively, t = 7.2, P < 0.01], and that in AI group [(28.6 +/- 3.7) U per milligram hydroxyproline] was also lower as compared with that in D group (t = -3.9, P < 0.05). There was no significant difference in AGE content between MI [(32.2 +/- 5.2) U per milligram hydroxyproline] and D groups (t = 1.6, P > 0.05). The percentage of KC in S phase was obviously lower in D group than in NC group [(5.3 +/- 0.6)%, (7.6 +/- 0.9)%, respectively, t = 4.50, P < 0.01], while that in MI group [(9.2 +/- 1.5)%] was higher as compared with that in D group ( t = 4.90, P < 0.01). It was more higher in AI group than in D group on KC percentage in S and G2/M phase (with t value respectively 6.80, 3.17, P values all below 0.01). The oxidative stress indexes of skin tissue in D group were all higher than those in NC group, in which levels of MPO and SOD showed statistical difference (with t value respectively 4.4, 3.7, P values all below 0.05). The oxidative stress indexes were all lower in AI group than in D group, especially in SOD level (t = -1.4, P < 0.05). Levels of MAD, MPO in MI group were significantly lower than those in D group (with t value respectively 2.6, 2.9, P values all below 0.05).
Aminoguanidine cream can promote KC proliferation and appropriately reduce oxidative stress through inhibiting AGE formation to a certain extent in skin tissue of rats with diabetes. Signal use of matrix cream can also reduce oxidative stress in skin tissue of rats with diabetes.
探讨氨基胍乳膏对糖尿病大鼠皮肤组织角质形成细胞(KC)增殖、晚期糖基化终末产物(AGE)含量及氧化应激的影响。
将硬脂酸、液体石蜡、凡士林、羊毛脂、肉豆蔻酸异丙酯、甘油、50 g/L乙醇对羟基苯甲酸酯、盐酸氨基胍等按一定比例混合制成氨基胍乳膏,以不含氨基胍的乳膏作为基质。取正常大鼠背部皮肤,分别用5 g/L、10 g/L氨基胍乳膏或5 g/L氨基胍乳膏联合10 g/L氮酮进行处理,于处理后2、4、7、10、12、24小时分别测定透皮效果。将30只SD大鼠按随机数字表法分为正常对照组(NC,n = 6)、糖尿病组(D,n = 8)、氨基胍乳膏干预组(AI,n = 8)、基质乳膏干预组(MI,n = 8)。对D、AI、MI组大鼠腹腔注射链脲佐菌素(STZ,65 mg/kg)制备糖尿病模型,NC组大鼠注射0.05 mmol/L枸橼酸盐缓冲液作为对照。1周后,对AI组和MI组大鼠背部皮肤分别外用10 g/L氨基胍乳膏和基质乳膏,连续4周。采用荧光检测法测定皮肤胶原提取物中AGE含量;采用流式细胞术检测KC细胞周期;取皮肤组织标本测定超氧化物歧化酶(SOD)、丙二醛(MDA)、髓过氧化物酶(MPO)水平及总抗氧化能力。数据采用t检验进行处理。
10 g/L氨基胍乳膏的透皮效果优于5 g/L氨基胍乳膏及5 g/L氨基胍乳膏联合10 g/L氮酮乳膏。MI组有1只大鼠造模未成功。造模后4周,D组有4只大鼠死亡,AI组有1只大鼠死亡。D组AGE含量明显高于NC组[分别为(36.8±2.6)、(24.6±2.7)U/毫克羟脯氨酸,t = 7.2,P < 0.01];AI组[(28.6±3.7)U/毫克羟脯氨酸]较D组降低(t = -3.9,P < 0.05)。MI组[(32.2±5.2)U/毫克羟脯氨酸]与D组AGE含量差异无统计学意义(t = 1.6,P > 0.05)。D组KC的S期百分比明显低于NC组[分别为(5.3±0.6)%、(7.6±0.9)%,t = 4.50,P < 0.01];MI组[(9.2±1.5)%]较D组升高(t = 4.90,P < 0.01)。AI组KC的S期和G2/M期百分比均高于D组(t值分别为6.80、3.17,P值均< 0.01)。D组皮肤组织氧化应激指标均高于NC组,其中MPO和SOD水平差异有统计学意义(t值分别为4.4、3.7,P值均< 0.05)。AI组氧化应激指标均低于D组,尤其是SOD水平(t = -1.4,P < 0.05)。MI组MDA、MPO水平明显低于D组(t值分别为2.6、2.9,P值均< 0.05)。
氨基胍乳膏可促进糖尿病大鼠皮肤组织KC增殖,并通过一定程度抑制AGE形成适度减轻氧化应激。单纯外用基质乳膏也可减轻糖尿病大鼠皮肤组织氧化应激。